Alphatec Holdings ATEC
NASDAQ ATEC
$9.31 -0.44 (-4.46%)
At close: Aug 20, 2026 · 1:17 PM UTC

Alphatec Holdings (ATEC) Liabilities and Shareholders Equity (2010 - 2026)

Alphatec Holdings (ATEC) posted Liabilities and Shareholders Equity of $799.5 million for Q1 2026, up 1.05% sequentially from $791.2 million in Q4 2025, and up 1.78% YoY from $785.5 million in Q1 2025.

Alphatec Holdings (ATEC) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

Alphatec Holdings has reported Liabilities and Shareholders Equity for 17 years, with the latest figure at $799.5 million in Q1 2026.

  • Quarterly Liabilities and Shareholders Equity rose 1.78% year-over-year to $799.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.2 billion (up 3.01% YoY) and the FY2025 annual result came in at $791.2 million, up 2.0% from the prior year.
  • Liabilities and Shareholders Equity advanced to $799.5 million in Q1 2026 per ATEC's latest filing, from $791.2 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $805.2 million in Q4 2023 and troughed at $511.9 million in Q2 2022.
  • A 5-year average of $693.5 million and a median of $768.6 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
  • The sharpest annual moves came in 2022 and 2023: Liabilities and Shareholders Equity retreated 13.68% in 2022, then soared 54.56% in 2023.
  • Over 5 years, Liabilities and Shareholders Equity stood at $521.0 million in 2022, then jumped by 54.56% to $805.2 million in 2023, then retreated by 3.66% to $775.7 million in 2024, then grew by 2.0% to $791.2 million in 2025, then gained by 1.05% to $799.5 million in 2026.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $799.5 million, $791.2 million, and $787.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 198.95 Bn 193.35 Bn 7.27 Bn 109.22 Bn
2 Stryker 128.10 Bn 124.63 Bn 4.50 Bn 47.93 Bn
3 Medtronic 118.91 Bn 109.69 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 73.43 Bn 72.89 Bn 3.85 Bn 45.22 Bn
5 Edwards Lifesciences 51.91 Bn 47.66 Bn 1.35 Bn 13.87 Bn
6 Dexcom 34.52 Bn 32.58 Bn 830.00 Mn 6.46 Bn
7 GE HealthCare Technologies 33.94 Bn 31.83 Bn 2.18 Bn 37.25 Bn
8 Koninklijke Philips 26.37 Bn 23.05 Bn 4.55 Bn 31.04 Bn
9 Steris 23.14 Bn 22.66 Bn 684.20 Mn 10.74 Bn
10 Alphatec Holdings 1.46 Bn 1.34 Bn 154.10 Mn 791.03 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 791.03 Mn
Mar 31, 2026 799.48 Mn
Dec 31, 2025 791.21 Mn
Sep 30, 2025 787.25 Mn
Jun 30, 2025 790.29 Mn
Mar 31, 2025 785.47 Mn
Dec 31, 2024 775.71 Mn
Sep 30, 2024 745.90 Mn
Jun 30, 2024 768.59 Mn
Mar 31, 2024 774.58 Mn
Dec 31, 2023 805.21 Mn
Sep 30, 2023 670.22 Mn
Jun 30, 2023 628.23 Mn
Mar 31, 2023 569.69 Mn
Dec 31, 2022 520.97 Mn
Sep 30, 2022 516.28 Mn
Jun 30, 2022 511.94 Mn
Mar 31, 2022 548.69 Mn
Dec 31, 2021 572.05 Mn
Sep 30, 2021 598.11 Mn